trametinibem
Trametinib is a medication used to treat certain types of cancer. It belongs to a class of drugs known as MEK inhibitors. These inhibitors work by targeting a specific pathway in cells called the MAPK pathway, which can become overactive in some cancers and promote tumor growth. Trametinib specifically inhibits MEK1 and MEK2, enzymes that are crucial components of this pathway.
It is primarily prescribed for advanced melanoma that has a BRAF V600E or V600K mutation. In combination
The administration of trametinib is typically oral, taken as tablets. Like all medications, it can cause side